138 related articles for article (PubMed ID: 28791697)
61. Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
Fang C; Li XP; Gong WJ; Wu NY; Tang J; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():21-29. PubMed ID: 27873337
[TBL] [Abstract][Full Text] [Related]
62. Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.
Cai W; Chen C; Li X; Shi J; Sun Q; Liu D; Sun Y; Hou L; Zhao X; Gu S; Wu Q; Chen H; Zhang W; Jin L; Lu D; Fei K; Su B; Qian J
Future Oncol; 2014 May; 10(7):1175-85. PubMed ID: 24947259
[TBL] [Abstract][Full Text] [Related]
63. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.
Hu L; Chen SH; Lv QL; Sun B; Qu Q; Qin CZ; Fan L; Guo Y; Cheng L; Zhou HH
Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27249003
[TBL] [Abstract][Full Text] [Related]
64. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Delgado JR; Calleja-Hernández MÁ; Faus-Dáder MJ
Pathol Res Pract; 2018 Jan; 214(1):44-52. PubMed ID: 29254785
[TBL] [Abstract][Full Text] [Related]
65. Genetic polymorphisms in the mismatch repair pathway (MMR) genes contribute to hematological and gastrointestinal toxicity in North Indian lung cancer patients treated with platinum-based chemotherapy.
Singh S; Singh N; Sharma S
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23183. PubMed ID: 35924411
[TBL] [Abstract][Full Text] [Related]
66. Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients.
Cao S; Wang C; Ma H; Yin R; Zhu M; Shen W; Dai J; Shu Y; Xu L; Hu Z; Shen H
Sci Rep; 2015 Jun; 5():11556. PubMed ID: 26100964
[TBL] [Abstract][Full Text] [Related]
67. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.
Stewart DJ; Chang DW; Ye Y; Spitz M; Lu C; Shu X; Wampfler JA; Marks RS; Garces YI; Yang P; Wu X
Pharmacogenomics J; 2014 Dec; 14(6):509-22. PubMed ID: 24980784
[TBL] [Abstract][Full Text] [Related]
68. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review.
Frederiks CN; Lam SW; Guchelaar HJ; Boven E
Cancer Treat Rev; 2015 Dec; 41(10):935-50. PubMed ID: 26585358
[TBL] [Abstract][Full Text] [Related]
69. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.
Chen J; Yin J; Li X; Wang Y; Zheng Y; Qian C; Xiao L; Zou T; Wang Z; Liu J; Zhang W; Zhou H; Liu Z
Int J Mol Sci; 2014 Nov; 15(11):21011-27. PubMed ID: 25405734
[TBL] [Abstract][Full Text] [Related]
70. Association of
Xu W; Liu D; Yang Y; Ding X; Sun Y; Zhang B; Xu J; Su B
J Thorac Dis; 2016 Sep; 8(9):2519-2529. PubMed ID: 27747004
[TBL] [Abstract][Full Text] [Related]
71. Pharmacogenomics of platinum-based chemotherapy in NSCLC.
Hildebrandt MA; Gu J; Wu X
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):745-55. PubMed ID: 19442035
[TBL] [Abstract][Full Text] [Related]
72. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Li R; Pu X; Chang JY; Ye Y; Komaki R; Minna JD; Roth JA; Han B; Wu X
PLoS One; 2016; 11(3):e0150467. PubMed ID: 26991123
[TBL] [Abstract][Full Text] [Related]
73. Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
Gong WJ; Peng JB; Yin JY; Li XP; Zheng W; Xiao L; Tan LM; Xiao D; Chen YX; Li X; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2017 Apr; 38(4):581-590. PubMed ID: 28260796
[TBL] [Abstract][Full Text] [Related]
74. Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancer.
Wang LY; Cui JJ; Liu JY; Guo AX; Zhao ZY; Liu YZ; Wu JC; Li M; Hu CP; Gao Y; Zhou HH; Yin JY
Sci Data; 2018 Dec; 5():180284. PubMed ID: 30531820
[TBL] [Abstract][Full Text] [Related]
75. Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Bins S; Basak EA; El Bouazzaoui S; Koolen SLW; Oomen-de Hoop E; van der Leest CH; van der Veldt AAM; Sleijfer S; Debets R; van Schaik RHN; Aerts JGJV; Mathijssen RHJ
Br J Cancer; 2018 May; 118(10):1296-1301. PubMed ID: 29695768
[TBL] [Abstract][Full Text] [Related]
76. Polymorphisms of
Liu D; Xu W; Ding X; Yang Y; Su B; Fei K
J Cancer; 2017; 8(18):3785-3794. PubMed ID: 29151966
[TBL] [Abstract][Full Text] [Related]
77. The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors.
Chen Y; Lin Y; Guan S; Zhao Z; Lin D; Guan J; Zhou C; Liu J; Cao X; Lin Z; Chen D; Shang J; Zhang W; Chen H; Chen L; Ma S; Gu L; Zhao J; Huang M; Wang X; Long H
Drug Metab Dispos; 2023 Dec; 51(12):1583-1590. PubMed ID: 37775332
[TBL] [Abstract][Full Text] [Related]
78. Pol ζ polymorphisms are associated with platinum based chemotherapy response and side effects among non-small cell lung cancer patients.
Ye J; Chu T; Li R; Niu Y; Jin B; Xia J; Shao M; Han B
Neoplasma; 2015; 62(5):833-9. PubMed ID: 26278154
[TBL] [Abstract][Full Text] [Related]
79. Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
Ziliak D; O'Donnell PH; Im HK; Gamazon ER; Chen P; Delaney S; Shukla S; Das S; Cox NJ; Vokes EE; Cohen EE; Dolan ME; Huang RS
Transl Res; 2011 May; 157(5):265-72. PubMed ID: 21497773
[TBL] [Abstract][Full Text] [Related]
80. Association of variations in platinum resistance-related genes and prognosis in lung cancer patients.
Zhou YK; Li XP; Yin JY; Zou T; Wang Z; Wang Y; Cao L; Chen J; Liu ZQ
J Cancer; 2020; 11(15):4343-4351. PubMed ID: 32489453
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
